Abstract
Get full access to this article
View all access options for this article.
References
1.
.
Daly
E
Gray
A
Barlow
D
McPherson
K
Roche
M
Vessey
M.
Measuring the impact of menopausal symptoms on quality of life . BMJ
1993 ; 307 : 836 –840 .
2.
.
Zethraeus
N.
Willingness to Pay for Hormone Replacement Therapy . Health Economics
1998 ; 7 : 31 –38 .
3.
.
Komulainen
MH
Kroger
H
Tuppurainen
MT
Heikkinen
AM
Alhava
E
Honkanen
R
. HRT and Vit D in prevention of non-vertebral fractures in posmenopausal women: a 5 year randomised trial . Maturitas
1998 ; 31 : 45 –54 .
4.
.
Torgerson
DJ
Reid
DM
. The economics of osteoporosis and its prevention . PharmacoEconomics
1997 ; 11 (2 ): 126 –138 .
5.
.
Michaelsson
K
Baron
JA
Farahmand
BY
Johnell
O
Magnusson
C
. Hormone Replacement therapy and the risk of hip fracture: population based case-control . BMJ
1998 ; 316 : 1858 –63 .
6.
.
Lufkin
EG
Wahner
HW
O'Fallon
WM
Hodgson
S
Kotowitz
MA
. Treatment of postmenopausal osteoporosis with transdermal estrogen . Annals of Internal Medicine
1992 ; 117 : 1 –9 .